Loading data
IMRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 0 USD | 316.95 k USD | 2.08 m USD |
| Cost of revenue | — | — | 0 USD | 158.12 k USD | 1.15 m USD |
| Gross profit | — | — | 0 USD | 158.83 k USD | 926.89 k USD |
| Research and development expense | 42.05 m USD | 47.96 m USD | 41.62 m USD | 36.27 m USD | 26.54 m USD |
| Operating profit | -59.38 m USD | -64.07 m USD | -58.41 m USD | -51.74 m USD | -33.89 m USD |
| Profit before tax | — | — | — | -50.51 m USD | -33.84 m USD |
| Income tax expense | 0 USD | — | — | — | -307.49 k USD |
| Net income (reported basis) | -56.02 m USD | -61.04 m USD | -53.47 m USD | -50.51 m USD | -33.54 m USD |
| Basic earnings per share | -1.27 USD/share | -2.04 USD/share | -1.88 USD/share | -1.91 USD/share | -2.46 USD/share |
| Diluted earnings per share | -1.27 USD/share | -2.04 USD/share | -1.88 USD/share | -1.91 USD/share | -2.46 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.